miR Sentinel™ Prostate Cancer Test
Prostate Cancer Detection, Risk Classification, and Monitoring
Key Facts
About miRNA Scientific
MiRNA Scientific is a private, commercial-stage diagnostics company developing a novel platform for cancer detection and management. Its core technology analyzes small non-coding RNAs (sncRNAs) from urinary exosomes to provide molecular evidence of prostate cancer and classify its risk aggressiveness. The company's initial product, the miR Sentinel™ Prostate Cancer Test, aims to address the significant shortcomings of the current prostate cancer screening standard of care, which relies on inaccurate PSA tests and invasive biopsies. MiRNA Scientific positions its solution as a scalable, efficient, and patient-friendly alternative that can improve early detection and reduce unnecessary procedures.
View full company profile